Managed Health Care Connect February 9, 2018
Eileen Koutnik-Fotopoulos

One year ago, the FDA released the health care economic information (HCEI) draft guidance on approved communication between pharmaceutical manufacturers and health care decision-makers, including payers, formulary committees, or similar entities. First Report Managed Care spoke with stakeholders for their insights and experiences on why access to HCEI is critical to better care for patients, how the guidance has impacted payers, why it is important to continue incorporating HCEI into decision making while waiting for FDA to finalize the guidelines, and where industry stands on HCEI a year later.

The Value of Access

HCEI, which is part of the 21st Century Cures Act, is an important consideration during the formulary decision-making process, according to Jay Jackson, PharmD, MPH, senior vice...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Cures Act, FDA, Payer
FDA issues flu vaccine recommendations: 5 respiratory updates
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns

Share This Article